DK0811001T3 - Benzothiazindioxider som endothelinantagonister - Google Patents

Benzothiazindioxider som endothelinantagonister

Info

Publication number
DK0811001T3
DK0811001T3 DK96903708T DK96903708T DK0811001T3 DK 0811001 T3 DK0811001 T3 DK 0811001T3 DK 96903708 T DK96903708 T DK 96903708T DK 96903708 T DK96903708 T DK 96903708T DK 0811001 T3 DK0811001 T3 DK 0811001T3
Authority
DK
Denmark
Prior art keywords
endothelin
endothelin antagonists
preparation
benzothiazine dioxides
dioxides
Prior art date
Application number
DK96903708T
Other languages
English (en)
Inventor
Annette Marian Doherty
Jeremy John Edmunds
Kent Alan Berryman
Amy Mae Bunker
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Application granted granted Critical
Publication of DK0811001T3 publication Critical patent/DK0811001T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D275/00Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D275/06Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/021,2-Thiazines; Hydrogenated 1,2-thiazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Dental Preparations (AREA)
  • Polyesters Or Polycarbonates (AREA)
DK96903708T 1995-02-21 1996-01-26 Benzothiazindioxider som endothelinantagonister DK0811001T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/393,143 US5599811A (en) 1995-02-21 1995-02-21 Benzothiazine dioxides as endothelin antagonists
PCT/US1996/001093 WO1996026195A1 (en) 1995-02-21 1996-01-26 Benzothiazine dioxides as endothelin antagonists

Publications (1)

Publication Number Publication Date
DK0811001T3 true DK0811001T3 (da) 2002-02-18

Family

ID=23553452

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96903708T DK0811001T3 (da) 1995-02-21 1996-01-26 Benzothiazindioxider som endothelinantagonister

Country Status (27)

Country Link
US (1) US5599811A (da)
EP (1) EP0811001B1 (da)
JP (1) JPH11501013A (da)
KR (1) KR19980702358A (da)
CN (1) CN1071327C (da)
AT (1) ATE207911T1 (da)
AU (1) AU720036B2 (da)
BG (1) BG62613B1 (da)
CA (1) CA2211027A1 (da)
CZ (1) CZ294412B6 (da)
DE (1) DE69616515T2 (da)
DK (1) DK0811001T3 (da)
EE (1) EE03564B1 (da)
ES (1) ES2167544T3 (da)
FI (1) FI973380A (da)
GE (1) GEP20001969B (da)
HU (1) HUP9800273A3 (da)
NO (1) NO308897B1 (da)
NZ (1) NZ302116A (da)
PL (1) PL321866A1 (da)
PT (1) PT811001E (da)
RO (1) RO116898B1 (da)
RU (1) RU2164225C2 (da)
SK (1) SK284275B6 (da)
UA (1) UA47424C2 (da)
WO (1) WO1996026195A1 (da)
ZA (1) ZA961342B (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5962490A (en) * 1987-09-25 1999-10-05 Texas Biotechnology Corporation Thienyl-, furyl- and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
US6030991A (en) * 1993-05-20 2000-02-29 Texas Biotechnology Corp. Benzenesulfonamides and the use thereof to modulate the activity of endothelin
US6376523B1 (en) 1994-05-20 2002-04-23 Texas Biotechnology Corporation Benzenesulfonamides and the use thereof to modulate the activity of endothelin
US6541498B2 (en) 1993-05-20 2003-04-01 Texas Biotechnology Benzenesulfonamides and the use thereof to modulate the activity of endothelin
US6613804B2 (en) 1993-05-20 2003-09-02 Encysive Pharmaceuticals, Inc. Biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
US6342610B2 (en) 1993-05-20 2002-01-29 Texas Biotechnology Corp. N-aryl thienyl-, furyl-, and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
KR100399797B1 (ko) * 1995-06-02 2004-04-13 시오노기세이야쿠가부시키가이샤 뇌부종억제제
US5804585A (en) 1996-04-15 1998-09-08 Texas Biotechnology Corporation Thieno-pyridine sulfonamides derivatives thereof and related compounds that modulate the activity of endothelin
US5783705A (en) * 1997-04-28 1998-07-21 Texas Biotechnology Corporation Process of preparing alkali metal salys of hydrophobic sulfonamides
BR9812258A (pt) 1997-04-28 2000-07-25 Texas Biotechnology Corp Sulfonamidas para tratamento de distúrbios mediados por endotelina
US6348474B1 (en) * 1997-06-27 2002-02-19 Fujisawa Pharmaceutical Co., Ltd. Sulfonamide compounds and medicinal use thereof
IL134057A0 (en) * 1997-09-05 2001-04-30 Warner Lambert Co Certain bezothiazine dioxide endothelin antagonists and processes for their preparation
GB2337048B (en) * 1998-05-05 2000-06-28 Warner Lambert Co 2,1,3-Benzothiadiazole containing endothelin antagonists
CA2409927A1 (en) * 2000-05-31 2001-12-06 Warner-Lambert Company Combinations of an endothelin receptor antagonist and an antiepileptic compound having pain alleviating properties or analgesic
US20020115661A1 (en) * 2000-12-07 2002-08-22 Keller Laurence Harvey Method for treating chronic obstructive pulmonary disease
US20100022568A1 (en) * 2006-04-13 2010-01-28 Actelion Pharmaceeuticals Ltd. Endothelin receptor antagonists for early stage idiopathic pulmonary fibrosis
FR2942797B1 (fr) * 2009-03-03 2011-04-29 Pf Medicament Derives de benzothiazines, leur preparation et leur application a titre de medicaments
EP3509588B1 (en) * 2016-09-12 2023-06-07 Integral Health,Inc. Bicyclic compounds useful as gpr120 modulators
CN112521384B (zh) * 2021-01-13 2021-11-02 湖北大学 溶剂热一锅法合成苯并噻嗪并环戊二烯衍生物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3237473A1 (de) * 1982-10-09 1984-04-12 Dr. Karl Thomae Gmbh, 7950 Biberach Neue 4-hydroxy-2h-1,2-benzothiazin-3-carboxamid-1,1-dioxide, verfahren zu ihrer herstellung, ihre verwendung und diese verbindungen enthaltende arzneimittel
CA2032559C (en) * 1989-12-28 2001-11-06 Kiyofumi Ishikawa Endothelin antagonistic cyclic pentapeptides
JPH0441483A (ja) * 1990-06-07 1992-02-12 Tanabe Seiyaku Co Ltd ベンゾチアジン誘導体及びその製法
JP2667294B2 (ja) * 1991-11-05 1997-10-27 スミスクライン・ビーチャム・コーポレイション エンドセリン受容体拮抗剤
US5389620A (en) * 1993-08-18 1995-02-14 Banyu Pharmaceutical Co., Ltd. Endothelin antagonistic heteroaromatic ring-fused cyclopentene derivatives

Also Published As

Publication number Publication date
NO308897B1 (no) 2000-11-13
RO116898B1 (ro) 2001-07-30
DE69616515T2 (de) 2002-05-16
WO1996026195A1 (en) 1996-08-29
CZ260797A3 (cs) 1998-06-17
SK114697A3 (en) 1998-08-05
EE9700147A (et) 1997-12-15
EP0811001B1 (en) 2001-10-31
HUP9800273A2 (hu) 1999-07-28
FI973380A (fi) 1997-08-20
EP0811001A1 (en) 1997-12-10
GEP20001969B (en) 2000-03-05
US5599811A (en) 1997-02-04
PT811001E (pt) 2002-04-29
DE69616515D1 (de) 2001-12-06
RU2164225C2 (ru) 2001-03-20
CA2211027A1 (en) 1996-08-29
EE03564B1 (et) 2001-12-17
BG101867A (en) 1998-10-30
NO973822D0 (no) 1997-08-20
HUP9800273A3 (en) 1999-09-28
NZ302116A (en) 1998-06-26
FI973380A0 (fi) 1997-08-18
CN1180351A (zh) 1998-04-29
BG62613B1 (bg) 2000-03-31
ATE207911T1 (de) 2001-11-15
ES2167544T3 (es) 2002-05-16
AU720036B2 (en) 2000-05-18
CN1071327C (zh) 2001-09-19
JPH11501013A (ja) 1999-01-26
CZ294412B6 (cs) 2004-12-15
PL321866A1 (en) 1997-12-22
UA47424C2 (uk) 2002-07-15
SK284275B6 (sk) 2004-12-01
NO973822L (no) 1997-08-21
KR19980702358A (ko) 1998-07-15
MX9706024A (es) 1997-11-29
ZA961342B (en) 1996-08-26
AU4770396A (en) 1996-09-11

Similar Documents

Publication Publication Date Title
DK0811001T3 (da) Benzothiazindioxider som endothelinantagonister
DK1094816T3 (da) Biphenylsulfonamider som dobbelte angiotensin-endothelin-receptorantagonister
TR200100267T2 (tr) İkameli anilid bileşimleri ve yöntemler.
EA200100972A1 (ru) Новые соединения и композиции как ингибиторы протеаз
EP1741713A3 (en) Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
DK0842934T3 (da) 5-HT1F agonister
NO990667D0 (no) Depeptid-benzamidin som kinogenase-inhibitor
FI973221A (fi) 1-aryyli-2-asyyliammo-etaaniyhdisteitä ja niiden käyttö neurokiniiniantagonisteina, erityisesti neurokiniini 1 antagonisteina
ATE195948T1 (de) Endothelinantagonisten
ATE139226T1 (de) Aminosulfonylharnstoff-acat-inhibitoren
NO20021503L (no) Kinazolinoner
BR9813719A (pt) Agentes terapêuticos
MY116277A (en) Certain benzothiazine dioxide endothelin antagonists and processes for their preparation
NO20002408L (no) 5-HT1F antagonister
TR199901416T2 (xx) Heterosiklik karbonikasit t�revleri.
ID27656A (id) Turunan azabisikloheptana n-tersubstitusi, pembuatan dan penggunaannya